GALDERMA
7.2.2024 07:01:36 CET | Business Wire | Press release
Galderma, the emerging pure-play dermatology category leader, is proud to present “NEXT by Galderma.” A ground-breaking report, NEXT takes a deep-dive into the global aesthetics trends set to shape 2024 and beyond. This project is the culmination of a year of comprehensive trend-forecasting research, conducted in collaboration with a network of renowned experts.
Aesthetics is increasingly becoming part of holistic beauty and well-being routines, which are, in turn, driving the category’s projected growth. By 2028, the aesthetics market is predicted to nearly double in value, reaching $25.9 billion.1
NEXT by Galderma offers a future-forward perspective on the aesthetics industry. The report identifies six key emerging trends, bolstered by three core macro movements that are supporting industry growth. These six key trends have the potential to shape the aesthetics landscape and become mainstream in the future. The report takes an in-depth look at these trends from a neutral standpoint, as well as at the societal and cultural aspects underpinning the evolution of the aesthetics industry.
Commissioned by Galderma and based on research from a leading trend-forecasting authority, the report is informed by extensive data and analysis. NEXT by Galderma was co-developed by a network of almost 40 of the world’s leading healthcare professionals and esteemed beauty and skincare influencers.
“In partnership with a renowned trend-forecasting agency, and in collaboration with revered healthcare professionals and influencers, we’ve identified six trends poised to shape the future of aesthetics. The trends that we see emerging now have the potential to become bigger and impact consumer decisions regarding their beauty and skincare choices. At Galderma, everything we do in the world of aesthetics is a manifestation of our belief in “Aesthetic Possibilities, Shaped Together.” It’s a new, more collaborative and future-facing approach that is at the core of NEXT by Galderma.”
GERRY MUHLE HEAD OF GLOBAL PRODUCT STRATEGY GALDERMA
|
NEXT by Galderma: The six trends that are anticipated to shape consumer demand in aesthetics
- Proactive Beauty: Addressing aging before it is apparent has become paramount. The rise of “prejuvenation” treatments, which focus on prevention rather than cure, reflects today’s zeitgeist. For aesthetics, this means an increased shift toward early intervention.
- Mindful Aesthetics: The ethos of mindful beauty has reached the aesthetics market. Consumers are increasingly embracing products with minimal environmental impact that align with their ethical values and provide natural-looking results. Additionally, there is demand for products that seamlessly integrate with the body, indicating a push-back against artifice.
- Fast Aesthetics: That trends in fashion and cosmetics come and go is nothing new. But the addition of aesthetics treatments into the mix is a more recent—and noteworthy—development. More and more people now want to use aesthetics to mimic the latest fast-moving trends.
- Beauty Fandom: There is a new and more extreme take on fandom at play in the aesthetics world today. This trend indulges in fascination with niche idolization—from cultural icons to digital filters, anime, and beyond—which is leading to a desire for metamorphosis.
- Expressionality: There is greater interplay between a sense of self and self-expression. We live in an era that encourages individuality in fashion, styling, hair, makeup and, now, aesthetic treatments. This trend celebrates the empowerment that comes from creating and enhancing one’s identity with aesthetics.
- Cancelling Age: Beauty today is for every age, at any age. We are cancelling expectations of what certain ages “should look like,” as consumers employ aesthetics to express their ageless attitude. This trend shows how the evolving desire to not be defined by our age is increasing demand to preserve and enhance beauty, rather than solely reverse aging.
The six trends are underpinned by three macro movements:
- Increasing accessibility: More convenient, more affordable, more inclusive. The exponential rise of minimally invasive treatments, as well as increased access to treatments via new clinic locations and treatment options, are factors that have reshaped the beauty industry. The desire for inclusivity has had a major impact on the world of aesthetics at large.
- Advancements in science and technology: The rise of aesthetic tech, new product innovations and improvements on existing products have expanded not only the variety of treatment options available, but also their appeal.
- Social community: Social media has heightened consumer awareness and understanding around aesthetic treatments. Aesthetic practitioners are using social media to garner sizeable followings, highlighting that the world of aesthetics has a far-reaching platform of increasing influence.
As Galderma continues to navigate what lies ahead, driven by “Aesthetic Possibilities, Shaped Together,” there remains a firm focus on advancing dermatology for every skin story. The skin we’re in shapes our lives. That’s why Galderma’s unparalleled portfolio—along with our commitment to staying at the forefront of emerging technologies, medical education, thought leadership and training—is essential to shaping the future of aesthetics.
To view the abridged version of the NEXT by Galderma report, click here.
About Galderma
Galderma is the emerging pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body’s largest organ—the skin—meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we’re in shapes our lives, we are advancing dermatology for every skin story. For more information: www.galderma.com.
References:
- Markets and Markets (2022): Medical Aesthetics Market - Global Forecast to 2027. Hadapsar: Markets and Markets, pp. 1–257. Available at: https://www.marketsandmarkets.com/Market-Reports/medical-aesthetics-market-885.html
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240206624555/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Sharjah Ruler Receives Portugal’s Grand Collar of Order of Camões31.1.2026 18:27:00 CET | Press release
His Excellency Marcelo Rebelo de Sousa, President of the Portuguese Republic, awarded His Highness Sheikh Dr Sultan bin Mohammed Al Qasimi, Supreme Council Member and Ruler of Sharjah, the Grand Collar of the Order of Camões (Grande Colar da Ordem de Camões), the highest sovereign cultural order in Portugal. His Highness is the first Arab figure to receive the Order of Camões and the sixth recipient worldwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260131119526/en/ Sharjah Ruler receives Portugal’s Grand Collar of Order of Camões (Photo: AETOSWire) The honour was conferred during a ceremony hosted by the Portuguese President at the Presidential Palace in Lisbon. The event was attended by Sheikha Bodour bint Sultan Al Qasimi, Chairperson of the Sharjah Book Authority, alongside senior officials. The ceremony recognised His Highness’s prominent global stature, as a leading figure in culture, intellectual thought and in
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release
Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release
The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release
Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
